Daniel Ferry | LifeSci Advisors |
William Clark | President, CEO & Director |
Diantha Duvall | CFO |
Thomas Davis | Chief Medical Officer |
Benjamin Burnett | Stifel, Nicolaus & Company |
Gil Blum | Needham & Company |
Michael Ulz | Robert W. Baird & Co. |
Good morning, ladies and gentlemen, and welcome to the Genocea Biosciences Second Quarter 2019 Financial Results. [Operator Instructions].
And without further delay, I would like to hand over the program to Mr. Dan Ferry. Sir, you may begin.